“Grade 2 fatty liver disease” is the term for moderate fatty liver disease and its symptoms. Fatty liver disease results from excessive buildup of fat in the liver. Medical professionals may grade ...

Vorasidenib becomes the first targeted therapy for grade 2 isocitrate dehydrogenase (IDH)–mutant glioma to receive FDA approval. "Today's approval of Voranigo is an enormous leap forward in cancer ...